Generated effect modifiers (GEM's) in randomized clinical trials.
暂无分享,去创建一个
Eva Petkova | R Todd Ogden | Thaddeus Tarpey | Zhe Su | T. Tarpey | E. Petkova | R. Ogden | Zhe Su
[1] Margaret Sullivan Pepe,et al. Evaluating Markers for Selecting a Patient's Treatment , 2004, Biometrics.
[2] Lacey Gunter,et al. Variable Selection for Qualitative Interactions in Personalized Medicine While Controlling the Family-Wise Error Rate , 2011, Journal of biopharmaceutical statistics.
[3] J. Robins,et al. Estimation of Regression Coefficients When Some Regressors are not Always Observed , 1994 .
[4] Lu Tian,et al. Adaptive index models for marker-based risk stratification. , 2011, Biostatistics.
[5] Min Zhang,et al. Estimating optimal treatment regimes from a classification perspective , 2012, Stat.
[6] Ian W McKeague,et al. Estimation of treatment policies based on functional predictors. , 2014, Statistica Sinica.
[7] S. Wellek. Testing for Absence of Qualitative Interactions Between Risk Factors and Treatment Effects , 1997 .
[8] John W. Tukey,et al. Use of many covariates in clinical trials , 1991 .
[9] Eric B. Laber,et al. Tree-based methods for individualized treatment regimes. , 2015, Biometrika.
[10] D A Follmann,et al. A Multivariate Test of Interaction for Use in Clinical Trials , 1999, Biometrics.
[11] Eva Petkova,et al. Treatment decisions based on scalar and functional baseline covariates , 2015, Biometrics.
[12] J. Robins,et al. Estimation and extrapolation of optimal treatment and testing strategies , 2008, Statistics in medicine.
[13] James M. Robins,et al. Optimal Structural Nested Models for Optimal Sequential Decisions , 2004 .
[14] Donglin Zeng,et al. Estimating Individualized Treatment Rules Using Outcome Weighted Learning , 2012, Journal of the American Statistical Association.
[15] Donglin Zeng,et al. On sparse representation for optimal individualized treatment selection with penalized outcome weighted learning , 2015, Stat.
[16] S. Murphy,et al. PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES. , 2011, Annals of statistics.
[17] S. Murphy,et al. Optimal dynamic treatment regimes , 2003 .
[18] J. Tukey. Tightening the clinical trial. , 1993, Controlled clinical trials.
[19] M. Gail,et al. Testing for qualitative interactions between treatment effects and patient subsets. , 1985, Biometrics.
[20] Hsuan-Yu Chen,et al. Survival Prediction Based on Compound Covariate under Cox Proportional Hazard Models , 2012, PloS one.
[21] Eric B. Laber,et al. A Robust Method for Estimating Optimal Treatment Regimes , 2012, Biometrics.
[22] Wenbin Lu,et al. Variable selection for optimal treatment decision , 2013, Statistical methods in medical research.
[23] Holly Janes,et al. Combining biomarkers to optimize patient treatment recommendations , 2014, Biometrics.
[24] J. Ware,et al. Detecting Moderator Effects Using Subgroup Analyses , 2013, Prevention Science.
[25] D. Schoenfeld,et al. Detecting treatment‐covariate interactions using permutation methods , 2015, Statistics in medicine.
[26] Donglin Zeng,et al. New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes , 2015, Journal of the American Statistical Association.
[27] Helena Chmura Kraemer,et al. Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach , 2013, Statistics in medicine.